Clinical and laboratory effects of recombinant human activated protein C in the treatment of a patient with sepsis-induced multiple organ failure

Author： Brueckmann M.   Wizenmann J.   Hoffmann U.   Seeger M.   Bewig B.  

Publisher： Elsevier

ISSN： 0049-3848

Source： Thrombosis Research, Vol.109, Iss.5, 2003-03, pp. : 259-263

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Effects of sepsis-induced acute lung injury on glycogen content in different tissues

By Rodrigues-Machado Maria da Glória   Silva Grazielle C.   Pinheiro Marina B.   Caliari Marcelo V.   Borges Elizabeth L.  

Experimental Lung Research, Vol. 36, Iss. 5, 2010-05 ,pp. : 302-306

Informa Healthcare

Access to resources Recommend Favorite

Sepsis-induced Cardiomyopathy

By  

Current Cardiology Reviews, Vol. 7, Iss. 3, 2011-08 ,pp. : 163-183

Bentham Science Publishers

Access to resources Recommend Favorite

Activation of recombinant human protein C

By Lee T.K.   Bangalore N.   Drohan W.N.   Lubon H.   Velander W.  

Thrombosis Research, Vol. 82, Iss. 3, 1996-05 ,pp. : 225-234

Elsevier

Access to resources Recommend Favorite

Human Protein C and Activated Protein C - Components of the Human Anticoagulation System

By Castellino F.J.  

Trends in Cardiovascular Medicine, Vol. 5, Iss. 2, 1995-03 ,pp. : 55-62

Elsevier

Access to resources Recommend Favorite

A randomized clinical trial comparing recombinant hyaluronan/recombinant albumin versus human tubal fluid for cleavage stage embryo transfer in patients with multiple IVF-embryo transfer failure

By Friedler Shevach   Schachter Morey   Strassburger Devorah   Esther Kasterstein   Ron El Raphael   Raziel Arieh  

Human Reproduction, Vol. 22, Iss. 9, 2007-09 ,pp. : 2444-2448

Oxford University Press

Access to resources Recommend Favorite